Vraylar 1.5 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FQFTC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,724
Award facts
- Contract value 100% obligated
- $33,723.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Vraylar 1.5 mg capsules (30-count units) valued at $33,723.97. This firm fixed-price delivery order, with an ultimate completion date of June 4, 2025, represents a competitive award with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Vraylar is a psychiatric medication used in the treatment of schizophrenia, bipolar disorder, and major depressive disorder, reflecting the ongoing pharmaceutical supply requirements of the Defense Health Agency and military healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical prime vendor agreement extending through December 2026. As a leading pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp maintains extensive contract awards with the DLA for a diverse portfolio of medications, vaccines, and medical supplies supporting military and veteran healthcare systems globally. The company's proven capability to fulfill federal medical supply requirements through competitive procurement processes positions it as a key supplier within the Defense Health Agency's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FQFTC?
SPE2DB25FQFTC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 3, 2025.
How much is contract SPE2DB25FQFTC worth?
The government has obligated $33,724 on SPE2DB25FQFTC.
Is contract SPE2DB25FQFTC an order under another contract?
Yes. SPE2DB25FQFTC is a delivery order under SPE2DB25D3005, an indefinite delivery contract.
Was contract SPE2DB25FQFTC competed?
The extent of competition for SPE2DB25FQFTC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award